Search

Your search keyword '"Meijer D"' showing total 1,209 results
Start Over Author "Meijer D"
1,209 results on '"Meijer D"'

1. Measuring school level attributable risk to support school-based HPV vaccination programs

Author

Vujovich-Dunn, C., Wand, H., Brotherton, J. M. L., Gidding, H., Sisnowski, J., Lorch, R., Veitch, M., Sheppeard, V., Effler, P., Skinner, S. R., Venn, A., Davies, C., Hocking, J., Whop, L., Leask, J., Canfell, K., Sanci, L., Smith, M., Kang, M., Temple-Smith, M., Kidd, M., Burns, S., Selvey, L., Meijer, D., Ennis, S., Thomson, C., Lane, N., Kaldor, J., and Guy, R.

Published
2022
Full Text
View/download PDF

2. The early oncological effect of extended pelvic lymph node dissection in men with at PSMA PET/CT N0M0 intermediate/high-risk prostate cancer - an international cohort study

Author

Van Leeuwen, P.J., primary, Berrens, A-C., additional, Vis, A., additional, Yaxley, J., additional, Meijer, D., additional, Siriwardana, A., additional, Wit, E., additional, Van Der Noort, V., additional, Morton, A., additional, Franklin, A., additional, Wong, D., additional, Goughlin, G., additional, Gianduzzo, T., additional, Kua, B., additional, Emmett, L., additional, Zuur, L., additional, Van Der Poel, H., additional, and Roberts, M., additional

Published
2024
Full Text
View/download PDF

3. External validation of the available nomograms for the identification of candidates for a staging extended pelvic lymph node dissection at the time of radical prostatectomy in prostate cancer patients preoperatively staged with PSMA PET

Author

Barletta, F.M., primary, Gandaglia, G., additional, Scuderi, S., additional, Robesti, D., additional, Rajwa, P., additional, Soeterik, T.F.W., additional, Bianchi, L., additional, Meijer, D., additional, Darr, C., additional, Guo, H., additional, Zattoni, F., additional, Fendler, W., additional, Marra, G., additional, Joniau, S., additional, Schiavina, R., additional, Mattei, A., additional, Fiori, C., additional, Porpiglia, F., additional, Picchio, M., additional, Van Den Bergh, R., additional, Shariat, S.F., additional, Chiti, A., additional, Montorsi, F., additional, and Briganti, A., additional

Published
2024
Full Text
View/download PDF

4. Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission

Author

Vis, A., primary, Meijer, D., additional, Roberts, M.J., additional, Siriwardana, A.R., additional, Morton, A., additional, Yaxley, J.W., additional, Samaratunga, H., additional, Emmett, L., additional, Van Der Ven, P.M., additional, Heymans, M.W., additional, Nieuwenhuijzen, J.A., additional, Van Der Poel, H.G., additional, Van Donswijk, M.L., additional, Boellaard, T.N., additional, Schoots, I.G., additional, Stricker, P., additional, Haynes, A-M., additional, Oprea-Lager, D.E., additional, Coughlin, G.D., additional, and Van Leeuwen, P.J., additional

Published
2024
Full Text
View/download PDF

5. Bio-Soliton Model that predicts Non-Thermal Electromagnetic Radiation Frequency Bands, that either Stabilize or Destabilize Life Conditions

Author

Geesink, J. H. and Meijer, D. K. F.

Subjects
Physics - General Physics
Abstract

Solitons, as self-reinforcing solitary waves, interact with complex biological phenomena such as cellular self-organisation. Soliton models are able to describe a spectrum of electromagnetism modalities that can be applied to understand the physical principles of biological effects in living cells, as caused by electromagnetic radiation. A bio-soliton model is proposed, that enables to predict which eigen-frequencies of non-thermal electromagnetic waves are life-sustaining and which are, in contrast, detrimental for living cells. The particular effects are exerted by a range of electromagnetic wave frequencies of one-tenth of a Hertz till Peta Hertz, that show a pattern of twelve bands, if positioned on an acoustic frequency scale. The model was substantiated by a meta-analysis of 240 published papers of biological radiation experiments, in which a spectrum of non-thermal electromagnetic waves were exposed to living cells and intact organisms. These data support the concept of coherent quantized electromagnetic states in living organisms and the theories of Davydov, Fr\"ohlich and Pang. A spin-off strategy from our study is discussed in order to design bio-compatibility promoting semi-conducting materials and to counteract potential detrimental effects due to specific types of electromagnetic radiation produced by man-made electromagnetic technologies., Comment: 24 pages, 8 figures

Published
2016

9. Improved oncologic outcomes after radical prostatectomy and lymph node dissection in patients who received staging PSMA PET/CT: A propensity score matched analysis

Author

Ettema, R.H., primary, Meijer, D., additional, Mellema, J.J., additional, van Leeuwen, P.J., additional, Luining, W.I., additional, van der Poel, H.G., additional, Donswijk, M.L., additional, Nieuwenhuijzen, J.A., additional, van den Bergh, R.C.N., additional, Oprea-Lager, D.E., additional, and Vis, A.N., additional

Published
2023
Full Text
View/download PDF

10. Using PSMA PET to Guide Prostate Biopsies and Stage Men at High-Risk of Prostate Cancer

Author

Bodar, Y.J.L., primary, Boevé, L.M.S., additional, van Leeuwen, P.J., additional, Baars, P.C., additional, Nieuwenhuijzen, J.A., additional, van Haarst, E.P., additional, Oddens, J.R., additional, Donswijk, M.L., additional, van Riel, L.A.M.N., additional, Scheltema, M.J.V., additional, Meijer, D., additional, Hendrikse, N.H., additional, Oprea-Lager, D.E., additional, and Vis, A.N., additional

Published
2023
Full Text
View/download PDF

15. Risk for progression in patients with pathological lymph-node metastatic disease (pN1) who underwent robot-assisted radical prostatectomy and extensive pelvic lymph node dissection.

Author

Wever, L., primary, Meijer, D., additional, Soeterik, T.F.W., additional, Ettema, R.H., additional, Baas, D.J.H., additional, Dijksman, L.M., additional, Somford, D.M., additional, van Leeuwen, P.J., additional, Beerlage, H.P., additional, van Basten, J.P.A., additional, van den Bergh, R.C.N., additional, and Vis, A.N., additional

Published
2023
Full Text
View/download PDF

16. The value of PSMA-PET in Addition to mpMRI and Systematic Biopsies to Select Patients for Hemi-ablative Focal Therapy in Prostate Cancer

Author

Scheltema, M.J.V., primary, Geboers, B., additional, Meijer, D., additional, Counter, W., additional, Thompson, J., additional, Doan, P., additional, Gondoputro, W., additional, Katelaris, A., additional, Haynes, A.M., additional, Delprado, W., additional, Vis, A., additional, van Leeuwen, P., additional, Ho, B., additional, Liu, V., additional, Lee, J., additional, Donswijk, M., additional, Oprea-Lager, D., additional, Emmett, L., additional, and Stricker, P., additional

Published
2023
Full Text
View/download PDF

17. PB0152 The Spectrum of FVIII-Specific Antibodies in Persons with Hemophilia A: A Cross-Sectional Nationwide Population Study

Author

Oomen, I., primary, Verhagen, M., additional, Miranda, M., additional, Allacher, P., additional, Kajen, P., additional, Hassan, S., additional, Meijer, D., additional, Rijpma, S., additional, Schweiger, H., additional, Fijnvandraat, K., additional, Voorberg, J., additional, Schols, S., additional, and Gouw, S., additional

Published
2023
Full Text
View/download PDF

20. In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype.

Author

Verhagen, M.J.A., Heerde, W.L. van, Bom, J.G. van der, Beckers, E.A., Blijlevens, N.M.A., Coppens, M., Gouw, S.C., Jansen, J.H., Leebeek, F.W.G., Vulpen, L.F. van, Meijer, D., Schols, S.E.M., Verhagen, M.J.A., Heerde, W.L. van, Bom, J.G. van der, Beckers, E.A., Blijlevens, N.M.A., Coppens, M., Gouw, S.C., Jansen, J.H., Leebeek, F.W.G., Vulpen, L.F. van, Meijer, D., and Schols, S.E.M.

Abstract

01 februari 2023, Item does not contain fulltext, BACKGROUND: Heterogeneity in clinical bleeding phenotype has been observed in hemophilia patients with similar FVIII or FIX activity levels. Thrombin generation and plasmin generation, as a global hemostasis assay, may contribute to a better prediction of which patients are at an increased risk of bleeding. OBJECTIVES: The objective of this study was to describe the association between clinical bleeding phenotype and thrombin generation and plasmin generation profiles in patients with hemophilia. METHODS: The Nijmegen Hemostasis Assay, which simultaneously measures thrombin and plasmin generation, was performed in plasma samples of patients with hemophilia participating in the sixth Hemophilia in the Netherlands study (HiN6). Patients receiving prophylaxis underwent a washout period. A severe clinical bleeding phenotype was defined as a self-reported annual bleeding rate of ≥5, a self-reported annual joint bleeding rate of ≥3, or the use of secondary/tertiary prophylaxis. RESULTS: In total, 446 patients, with a median age of 44 years, were included in this substudy. Thrombin generation and plasmin generation parameters differed between patients with hemophilia and healthy individuals. The median thrombin peak height was 1.0 nM, 25.9 nM, 47.1 nM, and 143.9 nM in patients with severe, moderate, and mild hemophilia and healthy individuals, respectively. A severe bleeding phenotype was observed in patients with a thrombin peak height of <49% and a thrombin potential of <72% compared to healthy individuals, and was independent of the hemophilia severity. The median thrombin peak height was 0.70% in patients with a severe clinical bleeding phenotype and 30.3% in patients with a mild clinical bleeding phenotype. The median thrombin potentials for these patients were 0.06% and 59.3%, respectively. CONCLUSION: A decreased thrombin generation profile is associated with a severe clinical bleeding phenotype in patients with hemophilia. Thrombin generation in combination with bl

Published
2023

21. The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A

Author

Valke, L.L.F.G., Verhagen, M.J.A., Mulders, Bart T.P.M., Polenewen, R., Blijlevens, N.M.A., Jansen, J.H., Rijpma, S.R., Schols, S.E.M., Heerde, W.L. van, Meijer, D., Valke, L.L.F.G., Verhagen, M.J.A., Mulders, Bart T.P.M., Polenewen, R., Blijlevens, N.M.A., Jansen, J.H., Rijpma, S.R., Schols, S.E.M., Heerde, W.L. van, and Meijer, D.

Abstract

Item does not contain fulltext

Published
2023

22. Laparoscopic peritoneal lavage or sigmoidectomy for perforated diverticulitis with purulent peritonitis: a multicentre, parallel-group, randomised, open-label trial

Author

Hop, W C, Opmeer, B C, Reitsma, J B, Scholte, R A, Waltmann, E W H, Legemate, D A, Bartelsman, J F, Meijer, D W, de Brouwer, M, van Dalen, J, Durbridge, M, Geerdink, M, Ilbrink, G J, Mehmedovic, S, Middelhoek, P, Di Saverio, Salomone, Boom, M J, Consten, E C J, van der Bilt, J D W, van Olden, G D J, Stam, M A W, Verweij, M S, Busch, O R C, Buskens, C J, El-Massoudi, Y, Kluit, A B, van Rossem, C C, Schijven, M P, Tanis, P J, Unlu, C, Gerhards, M F, Karsten, T M, de Nes, L C, Rijna, H, van Wagensveld, B A, Koffeman, G I, Steller, E P, Tuynman, J B, Bruin, S C, van der Peet, D L, Blanken-Peeters, C F J M, Cense, H A, Jutte, E, Crolla, R M P H, van der Schelling, G P, van Zeeland, M, de Graaf, E J R, Groenendijk, R P R, Vermaas, M, Schouten, O, de Vries, M R, Prins, H A, Lips, D J, Bosker, R J I, van der Hoeven, J A B, Diks, J, Plaisier, P W, Kruyt, P M, Sietses, C, Stommel, M W J, Nienhuijs, S W, de Hingh, I H J T, Luyer, M D P, van Montfort, G, Ponten, E H, Smulders, J F, van Duyn, E B, Klaase, J M, Swank, D J, Ottow, R T, Stockmann, H B A C, Vermeulen, J, Vuylsteke, R J C L M, Belgers, H J, Fransen, S, von Meijenfeldt, E M, Sosef, M N, van Geloven, A A W, Hendriks, E R, ter Horst, B, Leeuwenburgh, M M N, van Ruler, O, Vogten, J M, Vriens, E J C, Westerterp, M, Eijsbouts, Q A J, Bentohami, A, Bijlsma, T S, de Korte, N, Nio, D, Govaert, M J P M, Joosten, J J A, Tollenaar, R A E M, Stassen, L P S, Wiezer, M J, Hazebroek, E J, Smits, A B, van Westreenen, H L, Lange, J F, Brandt, A, Nijboer, W N, Toorenvliet, B R, Weidema, W F, Coene, P P L O, Mannaerts, G H H, den Hartog, D, de Vos, R J, Zengerink, J F, Hoofwijk, A G M, Hulsewé, K W E, Melenhorst, J, Stoot, J H M B, Steup, W H, Huijstee, P J, Merkus, J W S, Wever, J J, Maring, J K, Heisterkamp, J, van Grevenstein, W M U, Vriens, M R, Besselink, M G H, Borel Rinkes, I H M, Witkamp, A J, Slooter, G D, Konsten, J L M, Engel, A F, Pierik, E G J M, Frakking, T G, van Geldere, D, Patijn, G A, D'Hoore, A J L, de Buck van Overstraeten, A, Miserez, M, Terrasson, I, Wolthuis, A, De Blasiis, M G, Vennix, Sandra, Musters, Gijsbert D, Mulder, Irene M, Swank, Hilko A, Consten, Esther C, Belgers, Eric H, van Geloven, Anna A, Gerhards, Michael F, Govaert, Marc J, van Grevenstein, Wilhelmina M, Hoofwijk, Anton G, Kruyt, Philip M, Nienhuijs, Simon W, Boermeester, Marja A, Vermeulen, Jefrey, van Dieren, Susan, Lange, Johan F, and Bemelman, Willem A

Published
2015
Full Text
View/download PDF

23. A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and 18F-PSMA-PET/CT

Author

Bodar, Y.J.L., primary, Luining, W.I., additional, Keizer, B., additional, Meijer, D., additional, Vellekoop, A., additional, Schaaf, M., additional, Hendrikse, N.H., additional, Van Moorselaar, R.J.A., additional, Oprea-Lager, D.E., additional, and Vis, A.N., additional

Published
2022
Full Text
View/download PDF

24. Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases

Author

Valke, L.L.F.G., Rijpma, S.R., Meijer, D., Schols, S.E.M., and Heerde, W.L. van

Subjects
lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], Cardiology and Cardiovascular Medicine, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]
Abstract

Treatment of bleeding and thrombotic disorders is highly standardized and based on evidence-based medicine guidelines. These evidence-based treatment schemes are well accepted but may lead to either insufficient treatment or over-dosing, because the individuals’ hemostatic properties are not taken into account. This can potentially introduce bleeding or thrombotic complications in individual patients. With the incorporation of pharmacokinetic (PK) and pharmacodynamic (PK-PD) parameters, based on global assays such as thrombin generation assays (TGAs), a more personalized approach can be applied to treat either bleeding or thrombotic disorders. In this review, we will discuss the recent literature about the technical aspects of TGAs and the relation to diagnosis and management of bleeding and thrombotic disorders. In patients with bleeding disorders, such as hemophilia A or factor VII deficiency, TGAs can be used to identify patients with a more severe bleeding phenotype and also in the management with non-replacement therapy and/or bypassing therapy. These assays have also a role in patients with venous thrombo-embolism, but the usage of TGAs in patients with arterial thrombosis is less clear. However, there is a potential role for TGAs in the monitoring of (long-term) antithrombotic therapy, for example with the use of direct oral anticoagulants. Finally this review will discuss controversies, limitations and knowledge gaps in relation to the introduction of TGAs to personalize medicine in daily medical practice.

Published
2022

25. A Bayesian model for human directional localization of broadband static sound sources

Author

Barumerli, R., Majdak, P., Geronazzo, M., Meijer, D., Avanzini, F., and Baumgartner, R.

Subjects
Behavior, Bayesian inference, HRTF, Auditory model, Sound localization
Abstract

Humans estimate sound-source directions by combining prior beliefs with sensory evidence. Prior beliefs represent statistical knowledge about the environment while sensory evidence is acquired from auditory features such as interaural disparities and monaural spectral shapes. Models of directional sound localization often impose constraints on the contribution of these features to either the horizontal or vertical dimension. Instead, we propose a Bayesian model that more flexibly incorporates each feature according to its spatial precision and integrates prior beliefs in the inference process. We applied the model to directional localization of a single, broadband, stationary sound source presented to a static human listener in an anechoic environment. We simplified interaural features to be broadband and compared two model variants, each considering a different type of monaural spectral features: magnitude profiles and gradient profiles. Both model variants were fitted to the baseline performance of five listeners and evaluated on the effects of localizing with non-individual head-related transfer functions (HRTFs) and sounds with rippled spectrum. The model variant with spectral gradient profiles outperformed other localization models. This model variant appears particularly useful for the evaluation of HRTFs and may serve as a basis for future extensions towards modeling dynamic listening conditions.

Published
2022

27. A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the diagnostic performance of conventional imaging and 18F-PSMA-PET/CT

Author

Bodar, Y.J.L., primary, Luining, W., additional, Keizer, B., additional, Meijer, D., additional, Vellekoop, A., additional, Schaaf, M., additional, Hendrikse, N.H., additional, Van Moorselaar, R.J.A., additional, Oprea-Lager, D.E., additional, and Vis, A.N., additional

Published
2022
Full Text
View/download PDF

31. Von Willebrand disease type 2M: Correlation between genotype and phenotype

Author

Maas, D.P.M.S.M., Atiq, F., Blijlevens, N.M.A., Brons, P.P.T., Krouwel, S., Laros-van Gorkom, B.A.P., Leebeek, F.W.G., Nieuwenhuizen, Laurens, Schoormans, S.C.M., Simons, A., Meijer, D., Heerde, W.L. van, Schols, S.E.M., Maas, D.P.M.S.M., Atiq, F., Blijlevens, N.M.A., Brons, P.P.T., Krouwel, S., Laros-van Gorkom, B.A.P., Leebeek, F.W.G., Nieuwenhuizen, Laurens, Schoormans, S.C.M., Simons, A., Meijer, D., Heerde, W.L. van, and Schols, S.E.M.

Abstract

Item does not contain fulltext, BACKGROUND: An appropriate clinical diagnosis of von Willebrand disease (VWD) can be challenging because of a variable bleeding pattern and laboratory phenotype. Genotyping is a powerful diagnostic tool and may have an essential role in the diagnostic field of VWD. OBJECTIVES: To unravel the clinical and laboratory heterogeneity of genetically confirmed VWD type 2M patients and to investigate their relationship. METHODS: Patients with a confirmed VWD type 2M genetic variant in the A1 or A3 domain of von Willebrand factor (VWF) and normal or only slightly aberrant VWF multimers were selected from all subjects genotyped at the Radboud university medical center because of a high suspicion of VWD. Bleeding scores and laboratory results were analyzed. RESULTS: Fifty patients had a clinically relevant genetic variant in the A1 domain. Median bleeding score was 5. Compared with the nationwide Willebrand in the Netherlands study type 2 cohort, bleeding after surgery or delivery was reported more frequently and mucocutaneous bleedings less frequently. Median VWF activity/VWF antigen (VWF:Act/VWF:Ag) ratio was 0.32, whereas VWF collagen binding activity/VWF antigen (VWF:CB/VWF:Ag) ratio was 0.80. Variants in the A3 domain were only found in two patients with low to normal VWF:Act/VWF:Ag ratios (0.45, 1.03) and low VWF:CB/VWF:Ag ratios (0.45, 0.63). CONCLUSION: Genetically confirmed VWD type 2M patients have a relatively mild clinical phenotype, except for bleeding after surgery and delivery. Laboratory phenotype is variable and depends on the underlying genetic variant. Addition of genotyping to the current phenotypic characterization may improve diagnosis and classification of VWD.

Published
2022

32. Measuring school level attributable risk to support school-based HPV vaccination programs

Author

Vujovich-Dunn, C, Wand, H, Brotherton, JML, Gidding, H, Sisnowski, J, Lorch, R, Veitch, M, Sheppeard, V, Effler, P, Skinner, SR, Venn, A, Davies, C, Hocking, J, Whop, L, Leask, J, Canfell, K, Sanci, L, Smith, M, Kang, M, Temple-Smith, M, Kidd, M, Burns, S, Selvey, L, Meijer, D, Ennis, S, Thomson, C, Lane, N, Kaldor, J, Guy, R, Vujovich-Dunn, C, Wand, H, Brotherton, JML, Gidding, H, Sisnowski, J, Lorch, R, Veitch, M, Sheppeard, V, Effler, P, Skinner, SR, Venn, A, Davies, C, Hocking, J, Whop, L, Leask, J, Canfell, K, Sanci, L, Smith, M, Kang, M, Temple-Smith, M, Kidd, M, Burns, S, Selvey, L, Meijer, D, Ennis, S, Thomson, C, Lane, N, Kaldor, J, and Guy, R

Abstract

BACKGROUND: In Australia in 2017, 89% of 15-year-old females and 86% of 15-year-old males had received at least one dose of the HPV vaccine. However, considerable variation in HPV vaccination initiation (dose one) across schools remains. It is important to understand the school-level characteristics most strongly associated with low initiation and their contribution to the overall between-school variation. METHODS: A population-based ecological analysis was conducted using school-level data for 2016 on all adolescent students eligible for HPV vaccination in three Australian jurisdictions. We conducted logistic regression to determine school-level factors associated with lower HPV vaccination initiation (< 75% dose 1 uptake) and estimated the population attributable risk (PAR) and the proportion of schools with the factor (school-level prevalence). RESULTS: The factors most strongly associated with lower initiation, and their prevalence were; small schools (OR = 9.3, 95%CI = 6.1-14.1; 33% of schools), special education schools (OR = 5.6,95%CI = 3.7-8.5; 8% of schools), higher Indigenous enrolments (OR = 2.7,95% CI:1.9-3.7; 31% of schools), lower attendance rates (OR = 2.6,95%CI = 1.7-3.7; 35% of schools), remote location (OR = 2.6,95%CI = 1.6-4.3; 6% of schools,) and lower socioeconomic area (OR = 1.8,95% CI = 1.3-2.5; 33% of schools). The highest PARs were small schools (PAR = 79%, 95%CI:76-82), higher Indigenous enrolments (PAR = 38%, 95%CI: 31-44) and lower attendance rate (PAR = 37%, 95%CI: 29-46). CONCLUSION: This analysis suggests that initiatives to support schools that are smaller, with a higher proportion of Indigenous adolescents and lower attendance rates may contribute most to reducing the variation of HPV vaccination uptake observed at a school-level in these jurisdictions. Estimating population-level coverage at the school-level is useful to guide policy and prioritise resourcing to support school-based vaccination programs.

Published
2022

35. Restaging prostate-specific membrane antigen positron emission tomography/ computed tomography is associated with improved oncological outcome in men who underwent salvage radiation therapy for biochemically recurrent prostate cancer

Author

Meijer, D., primary, Eppinga, W.S.C., additional, Mohede, R.M., additional, Vanneste, B.G.L., additional, Meijnen, P., additional, Meijer, O.W.M., additional, Daniels, L.A., additional, Van Den Bergh, R.C.N., additional, Lont, A.P., additional, Ettema, R.H., additional, Oudshoorn, F.H.K., additional, Van Leeuwen, P.J., additional, Van Der Poel, H.G., additional, Donswijk, M.L., additional, Oprea-Lager, D.E., additional, Schaake, E.E., additional, and Vis, A.N., additional

Published
2022
Full Text
View/download PDF

36. Development of a novel nomogram to identify candidates for extended pelvic lymph-node dissection in prostate cancer using MRI and PSMA pet

Author

Meijer, D., primary, Vis, A.N., additional, Roberts, M.J., additional, Siriwardana, A.R., additional, Morton, A., additional, Yaxley, J.W., additional, Samaratunga, H., additional, Emmett, L., additional, Van De Ven, P.M., additional, Heijmans, M.W., additional, Van Der Poel, H.G., additional, Donswijk, M.L., additional, Boellaard, T.N., additional, Schoots, I.G., additional, Oprea-Lager, D.E., additional, Coughlin, G.D., additional, and Van Leeuwen, P.J., additional

Published
2022
Full Text
View/download PDF

37. Prospective analysis of Prostate Cancer Local Staging with 18F-DCFPyL PET/MRI combined with multiparametric MRI - a comparison to histopathology in the radical prostatectomy specimen

Author

Bodar, Y., Zwezerijnen, G. J., van der Voorn, J. P., Jansen, B., Smit, R., Kol, S., Meijer, D., De Bie, K., Windhorst, A., Hendrikse, N., Vis, A., Oprea-Lager, D., Urology, Cancer Center Amsterdam, Radiology and nuclear medicine, Pathology, Amsterdam Neuroscience - Cellular & Molecular Mechanisms, Neurology, Amsterdam Neuroscience - Brain Imaging, and CCA - Imaging and biomarkers

Published
2021

39. Standardized Uptake Values as Determined on Prostate-specific Membrane Antigen Positron Emission Tomography/Computer Tomography are associated with Gleason Grade and Biochemical Recurrence of Disease in Patients with Prostate Cancer

Author

Bodar, Y., Veerman, H., De Bie, K., Meijer, D., Hendrikse, H. N., van Leeuwen, P. J., Windhorst, B. A., Donswijk, M., Boellaard, R., Vis, A. N., Oprea-Lager, D. E., Urology, Cancer Center Amsterdam, Radiology and nuclear medicine, CCA - Imaging and biomarkers, Surgery, and Amsterdam Neuroscience - Brain Imaging

Published
2021

45. The role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography (PSMA PET/CT) in the selection of patients for salvage radiation therapy after radical prostatectomy

Author

Meijer, D., primary, Mohede, R.M., additional, Eppinga, W.S.C., additional, Vanneste, B.G.L., additional, Meijnen, P., additional, Daniels, L.A., additional, Van Den Bergh, R.C.N., additional, Lont, A.P., additional, Ettema, R.H., additional, Oudshoorn, F.H.K., additional, Van Leeuwen, P.J., additional, Van Der Poel, H.G., additional, Donswijk, M.L., additional, Oprea-Lager, D.E., additional, Schaake, E.E., additional, and Vis, A.N., additional

Published
2021
Full Text
View/download PDF

46. External validation and addition of PSMA-PET to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: An international multicenter study

Author

Meijer, D., primary, Van Leeuwen, P.J., additional, Roberts, M.J., additional, Siriwardana, A.R., additional, Morton, A., additional, Yaxley, J.W., additional, Samaratunga, H., additional, Emmett, L., additional, Van De Ven, P.M., additional, Van Der Poel, H.G., additional, Donswijk, M.L., additional, Boellaard, T.N., additional, Schoots, I.G., additional, Oprea-Lager, D.E., additional, Coughlin, G.D., additional, and Vis, A.N., additional

Published
2021
Full Text
View/download PDF

47. Prospective analysis of prostate cancer local staging with [18F]PSMA PET/MRI combined with multiparametric MRI – A comparison to histopathology in the radical prostatectomy specimen. – ProStaPET –

Author

Bodar, Y.J.L., primary, Zwezerijnen, G.J.C., additional, Van Der Voorn, J.P., additional, Jansen, B.H.E., additional, Smit, R.S., additional, Kol, S.Q., additional, Meijer, D., additional, De Bie, K., additional, Yaqub, M., additional, Windhorst, A.D., additional, Hendrikse, N.H., additional, Vis, A., additional, and Oprea-Lager, D.E., additional

Published
2021
Full Text
View/download PDF

48. Differences in school factors associated with adolescent HPV vaccination initiation and completion coverage in three Australian states

Author

Sisnowski, J., primary, Vujovich-Dunn, C., additional, Gidding, H., additional, Brotherton, J., additional, Wand, H., additional, Lorch, R., additional, Veitch, M., additional, Sheppeard, V., additional, Effler, P., additional, Skinner, S.R, additional, Venn, A., additional, Davies, C., additional, Hocking, J., additional, Whop, L., additional, Leask, J., additional, Canfell, K., additional, Sanci, L., additional, Smith, M., additional, Kang, M., additional, Temple-Smith, M., additional, Kidd, M., additional, Burns, S., additional, Selvey, L., additional, Meijer, D., additional, Ennis, S., additional, Thomson, C., additional, Lane, N., additional, Kaldor, J., additional, and Guy, R., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results